BridgeMD
New treatment option for Refractory Chronic Cough
Official title Group Telehealth Behavioral Cough Suppression Therapy
ClinicalTrials.gov ID: NCT06706765
What this study is testing
- What it's testing
- The purpose of this study is to investigate the effectiveness of behavioral cough suppression therapy (BCST) in managing refractory chronic cough (RCC) within a group telehealth setting. RCC is a cough that has lasted at least 8 weeks and has not resolved with standard medical treatment.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- At least 18 years old
- Predominantly dry cough for at least 8 weeks
- Evaluated and treated by at least one physician for cough
- Obtained a chest X-ray or chest CT scan specifically related to the cough with unremarkable results
- Access to a computer or tablet that includes a camera and able to use the device independently
You likely can't join if
- Under age 18
- Coughing up blood
- Current smoker of any substance
- History of smoking or 10 or more years
- Diagnosed with a chronic lung condition (e.g., COPD, emphysema, lung cancer, idiopathic pulmonary fibrosis, chronic bronchitis, asthma)? (NOTE: If a...
- Diagnosed currently or in the past with head and neck cancer (i.e., cancer of the mouth, nose, or throat).
See the full eligibility criteria
- At least 18 years old
- Predominantly dry cough for at least 8 weeks
- Evaluated and treated by at least one physician for cough
- Obtained a chest X-ray or chest CT scan specifically related to the cough with unremarkable results
- Access to a computer or tablet that includes a camera and able to use the device independently
- Reliable internet access
- Willing to agree to maintain confidentiality of personal information (including names) related to others in the study
- Under age 18
- Coughing up blood
- Current smoker of any substance
- History of smoking or 10 or more years
- Diagnosed with a chronic lung condition (e.g., COPD, emphysema, lung cancer, idiopathic pulmonary fibrosis, chronic bronchitis, asthma)? (NOTE: If a patient has been told their cough may be (or is likely) due to asthma...
- Diagnosed currently or in the past with head and neck cancer (i.e., cancer of the mouth, nose, or throat).
- Complaints of swallowing difficulty
- Taking any of the following medications, which have a known side effect of cough: Benzapril (Lotensin), Captopril (Capoten), Enalapril/Enalaprilat (Vasotec oral and injectable), Fosinopril (Monopril), Lisinopril...
- Prior BCST treatment with an SLP or respiratory therapist
The study team makes the final eligibility decision.
Where it's taking place
- Missoula, Montana, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Missoula, Montana, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.